Treatment of Typhoid Fever

Diagnostic Considerations

• The Widal test should not be used for diagnosis of enteric fever due to poor performance characteristics, with low specificity (68.44%) and very poor positive predictive value (5.7%) 1
• Blood cultures remain the gold standard for diagnosis, not the Widal test 1

Immediate Management Steps

• Collect blood cultures before starting antibiotics whenever possible, as they have the highest yield (40-80% sensitivity) within the first week of symptom onset 2, 3, 4
• If the patient is clinically unstable or has sepsis features, start empiric treatment immediately after collecting cultures 5, 4

First-Line Treatment Algorithm

• Azithromycin 500 mg once daily for 7 days is the preferred first-line treatment for adults with a significant Widal titre suggesting typhoid fever, particularly given widespread fluoroquinolone resistance exceeding 70% in endemic regions 2, 3, 4
• Azithromycin demonstrates significantly lower clinical failure rates (OR 0.48) compared to fluoroquinolones 2, 3
• Hospital stays are approximately 1 day shorter with azithromycin compared to fluoroquinolones 2, 3
• Relapse risk is dramatically lower (OR 0.09) compared to ceftriaxone 2, 3
• For children, Azithromycin 20 mg/kg/day (maximum 1g/day) for 7 days is recommended 2, 3
• For severe cases requiring IV therapy, Ceftriaxone 1-2g IV/IM daily for 5-7 days in adults and Ceftriaxone 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days in children are recommended 2, 3, 4

Geographic Considerations

• Do not use ciprofloxacin empirically for cases from South or Southeast Asia, where resistance approaches 96% in some regions 2, 3
• Fluoroquinolone resistance exceeds 70% in isolates from South Asia 2, 3
• Ciprofloxacin remains an alternative only if the patient traveled from sub-Saharan Africa 5

Monitoring and Expected Response

• Expect fever clearance within 4-5 days of appropriate antibiotic therapy 2, 3, 4
• Continue treatment for the full 7-day course (or 14 days per some guidelines) to prevent relapse, which occurs in 10-15% of inadequately treated cases 2, 4
• Relapse rates are <8% for ceftriaxone and <3% for azithromycin when full courses are completed 4

Common Pitfalls to Avoid

• Never discontinue antibiotics prematurely, even if fever resolves early 2
• Never rely solely on the Widal test for diagnosis—it has poor positive predictive value and should be supplemented with blood cultures 1
• Never use empiric ciprofloxacin for cases from Asia due to widespread resistance 2, 3

Adverse Effects to Monitor

• Common azithromycin adverse effects include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 2, 3
• Monitor for potential drug interactions with azithromycin, particularly QT-prolonging medications 2

Watch for Complications

• Complications such as gastrointestinal bleeding, intestinal perforation, and typhoid encephalopathy occur in 10-15% of patients 4
• Intestinal perforation typically occurs in patients with illness duration exceeding 2 weeks 2
• Surgical intervention with simple excision and closure is required for perforation, with success rates up to 88.2% 2

Management of Enteric (Typhoid) Fever: Duration, Diagnosis, and Treatment Recommendations

Natural History of Untreated Disease

• Life‑threatening complications such as intestinal perforation and encephalopathy typically arise in the second week of untreated illness and occur in approximately 10–15 % of patients whose disease duration exceeds two weeks【6】.

Fever Clearance with Antimicrobial Therapy

• Fever generally resolves within 4–5 days after initiating appropriate antibiotic therapy【6】.
• When the causative organism is susceptible, fluoroquinolones achieve the fastest fever clearance, often in less than 4 days【6】.

Diagnostic Yield of Cultures

• Blood cultures provide the highest diagnostic yield, with sensitivity up to about 80 % when performed within the first week of symptom onset【7】.
• The incubation period of enteric fever averages 7–18 days (range 3–60 days), so most travelers develop symptoms after returning home【7】.
• Stool and urine cultures become reliably positive only after the first week of illness【6】.

Treatment Duration to Prevent Relapse

• Completing a full 14‑day antibiotic course is recommended to minimize relapse risk, even if fever resolves earlier【6】.
• Relapse rates with adequate therapy are reported to be less than 8 % for ceftriaxone and less than 3 % for azithromycin【6】.

Clinical Pitfalls and Fever Persistence

• If fever persists beyond 48 hours of appropriate antibiotic therapy in a clinically stable patient, clinicians should reassess for alternative diagnoses or complications rather than empirically changing the antibiotic regimen【6】.
• Persistent fever beyond 3 days despite empirical therapy should trigger a thorough investigation for breakthrough infections or complications【8】.

Evidence‑Based Management of Salmonella Typhi Bacteremia

Antimicrobial Susceptibility and First‑Line Choices

• Azithromycin retains activity against 95 % of S. Typhi isolates, and completing a full course reduces relapse to less than 3 %【9】.
• Ceftriaxone demonstrates 100 % susceptibility of contemporary S. Typhi isolates, with relapse rates below 8 % when administered for an adequate duration【9】.

Geographic Resistance Patterns

• Empiric fluoroquinolones should be avoided in patients returning from South or Southeast Asia because ciprofloxacin resistance in these regions approaches 70–97 %【9】.
• More than 70 % of S. Typhi isolates imported into the United Kingdom are resistant to fluoroquinolones【9】.
• In endemic areas such as Nepal and Pakistan, 89–97 % of isolates exhibit resistance or reduced susceptibility to ciprofloxacin【9】.

Treatment Duration and Relapse Prevention

• Inadequate therapy (shorter than 14 days) is associated with a 10–15 % relapse rate; completing a full 14‑day regimen markedly lowers this risk【9】.
• A 7‑day azithromycin regimen yields relapse rates under 3 %; extending therapy to 14 days further reduces relapse risk【9】.
• Ceftriaxone requires a 14‑day course to achieve relapse rates below 8 %【9】.
• Complications such as intestinal perforation and encephalopathy occur in 10–15 % of patients whose illness extends beyond two weeks【9】.

Alternative Regimens When First‑Line Agents Unavailable

• If azithromycin cannot be used, ceftriaxone 1–2 g IV/IM daily for 7–14 days is recommended; oral cefixime may be used for completion but has reported failure rates ranging from 4 % to 37.6 %【9】.

Diagnostic Strategies

• The Widal test has poor specificity (≈ 68 %) and a very low positive predictive value (≈ 6 %); it should not be used to guide diagnosis or treatment decisions【9】.
• Blood cultures remain the gold‑standard diagnostic method, with a sensitivity of 40–80 % during the first week of illness【9】.
• Stool and urine cultures become reliably positive only after the first week of illness【9】.

Fluoroquinolone Susceptibility Testing

• Ciprofloxacin disc diffusion alone is insufficient to declare an isolate susceptible; concurrent susceptibility to nalidixic acid is required to confirm true fluoroquinolone susceptibility【9】.

Public Health and Prevention

• Approximately 81 % of typhoid fever cases in the United States report recent international travel, underscoring the need for travel‑related risk assessment【9】.
• Chronic carriage occurs in 3–5 % of patients, with gallstone disease markedly prolonging fecal shedding【9】.
• Typhoid vaccines (oral Ty21a or parenteral Vi‑polysaccharide) provide 50–80 % protection and are recommended for close contacts and future travelers【9】.